An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial

Keyphrases

• Ulcerative Colitis 100%
• Randomized Placebo-controlled Trial 100%
• Mesalamine 100%
• Oral Preparation 100%
• Long-term Maintenance Therapy 100%
• Treatment Efficacy 40%
• Remission 30%
• Adverse Events 30%
• Placebo 20%
• Treatment Failure 20%
• Placebo Groups 20%
• Oral Dosage Forms 20%
• Medical Center 10%
• Clinically Significant Change 10%
• University-based 10%
• Randomized Clinical Trial 10%
• Polymer-coated 10%
• Ohio 10%
• Placebo-controlled 10%
• Hematologic 10%
• Sulfasalazine 10%
• Stable Dose 10%
• Cincinnati 10%
• Private Practice 10%
• Laboratory Analysis 10%
• Oral Formulation 10%
• Maintenance of Remission 10%
• Intention-to-treat Analysis 10%
• Asacol 10%
• Gambling 10%
• PH-sensitive Polymer 10%
• Laboratory Profile 10%
• Proctosigmoidoscopy 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Aminosalicylic Acid 100%
• Placebo 100%
• Ulcerative Colitis 100%
• Remission 36%
• Adverse Event 27%
• Sulfasalazine 9%
• Tablet 9%
• Randomized Clinical Trial 9%